A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/15/1999	CN1238210A Externalty used paste for treating leukoderma, leukoplakia valvae and other vitiligines, and its preparing method
12/15/1999	CN1238208A Detoxicating instant particles and preparing method thereof
12/15/1999	CN1238184A Method for raising pigs and promoting them stronger
12/15/1999	CN1238181A Nefazodone dosage form
12/15/1999	CN1238180A Medicinal composition for curing sexual function involution and impotence and preparing process thereof
12/15/1999	CN1238179A 避孕栓 Contraceptive suppository
12/15/1999	CN1238176A Combination use of L-2-oxothiazolidine-4-carboxylic acid and polylol
12/15/1999	CN1047403C Process for the preparation of large ring lactone antibiotic
12/15/1999	CN1047387C Semiantigen compound, synthesizing process and use thereof
12/15/1999	CN1047386C Novel spiro [indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
12/15/1999	CN1047385C 3-indolylpiperidine and medinal composition containing them
12/15/1999	CN1047308C Oral pill for treatment of toothache
12/15/1999	CN1047307C Application of aucubine for the treatment of hepatitis B virus (HBV) infection
12/15/1999	CN1047306C Gynostemma pentaphyllum prednisone and its preparing process
12/15/1999	CN1047305C 可注射的组合物 Injectable compositions
12/15/1999	CA2274365A1 Compounds and compositions containing them useful for the transfer of active substances into a cell
12/14/1999	US6002022 Method for preparing 4, 10-diacetoxy-2α-benzoyloxy-5β, 20-Epoxy-1, 7β-dihydroxy-9-oxo-tax-11-en-13α-yl(2R,3S)-3-benzoylamino-2-h ydroxy-3-phenylpropionate trihydrate
12/14/1999	US6002014 Selectively inhibiting the action of cox-2; treating inflammation
12/14/1999	US6002012 Process for the preparation of [(5,6-dicarboxy-3-pyridyl) methyl] ammonium halides
12/14/1999	US6002009 Di-substituted 1,4-piperidine esters and amides having 5-HT4 antagonistic activity
12/14/1999	US6002002 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
12/14/1999	US6002001 Spin trapping pharmaceutical compositions and methods for use thereof
12/14/1999	US6001998 Macrocyclic lactone compounds and their production process
12/14/1999	US6001992 Oligonucleotides which promote apoptosis; anticarcinogenic agents, viricides, and treatment of autoimmune disorders
12/14/1999	US6001990 Antisense inhibition of hepatitis C virus
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001885 Retinoid inhibition of expression of VEGF
12/14/1999	US6001884 (substituted phenylene)alkylaminealkyl phenylene compounds of given formula; administering to treat disorders characterized by abnormal calcium homeostasis such as hyperparathyroidism, paget's disease, osteoporosis and hypertension
12/14/1999	US6001882 Photoactivated hypericin and the use thereof
12/14/1999	US6001881 Administering to treat arrhythmia, angina pectoris, ischemia, shock, cell proliferation, fibrotic diseases, prostate hyperplasia, fat metabolism disorders, and as a preservative for transplant organs, or to prepare a patient for surgery
12/14/1999	US6001880 Disubstituted n-(2-dialkylaminoethyl)benzamide derivatives of given formula; antibacterial activity against helicobacter pyroli, administering for the prevention or cure of peptic ulcers
12/14/1999	US6001878 Enterally administering a glutamine or glutamine equivalent in specific dosage to treat a diseased state associated with low arginine plasma levels, such as systemic inflammation, high arginase levels, jaundice, and liver transplantation
12/14/1999	US6001876 Administering analogs of 4-aminobutyric acid to treat pain in mammals
12/14/1999	US6001875 Administering diclofenac which protects against nonenzymatic glycation of albumin and lowers the serum concentration of glycated albumin, such as amadori compounds, implicated in kidney dysfunction of diabetes and aging
12/14/1999	US6001870 Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media
12/14/1999	US6001868 Administering to an individual an effective amount of an indole-3-carbinol compound or a derivative to treat tumor cell growth
12/14/1999	US6001866 Method for treating and preventing inflammation and atherosclerosis
12/14/1999	US6001864 Antifungal agent
12/14/1999	US6001861 Use of pramipexole in the treatment of restless legs syndrome
12/14/1999	US6001860 N-heteroaryl substituted thiourea or urea derivatives used to reduce cholesterol in blood stream, therefore useful to prevent cardiovascular disorders
12/14/1999	US6001856 β-adrenergic agonists to reduce a wasting condition
12/14/1999	US6001855 Thiazole derivatives
12/14/1999	US6001853 Composition further comprising a reducing agent for maintaining the hydroxylamine in a reduced form.
12/14/1999	US6001852 Clioquinol for the treatment of Alzheimer's disease
12/14/1999	US6001849 Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission
12/14/1999	US6001848 Bromocriptine for the treatment of alcoholics diagnosed with the D2 dopamine receptor DRD2 A1 allele
12/14/1999	US6001847 Chemical compounds
12/14/1999	US6001845 Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
12/14/1999	US6001844 4-Azasteroids for treatment of hyperandrogenic conditions
12/14/1999	US6001843 Substituted pyridines as selective cyclooxygenase-2 inhibitors
12/14/1999	US6001842 Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury
12/14/1999	US6001840 Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs
12/14/1999	US6001839 Substituted 4-amino-7H-pyrrolo [2,3,-d]-pyrimidines as PTK inhibitors
12/14/1999	US6001837 Methods of treating or preventing sleep apnea
12/14/1999	US6001834 [(4-heteroaryl-1-piperazinyl)alkoxy]-3,4-dihydro-1(2h)-naphthalenones and related compounds and their therapeutic utility
12/14/1999	US6001833 Novel piperazine derivatives which are substituted in the 2-position by an indolylmethyl radical and in which the nitrogen in the 4-position of the piperazine ring forms part of a urea structure bearing a benzylaminoethyl substituent
12/14/1999	US6001832 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
12/14/1999	US6001830 Heterocyclic compounds
12/14/1999	US6001828 Thalidomide and an effective amount of a 5-(2-imidazolyl-8-chloro-2-(methylamino)-1,2-dihydro-1,4-benzo diazepine reverse transcriptase inhibitor
12/14/1999	US6001826 Chemical compounds
12/14/1999	US6001823 Novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones
12/14/1999	US6001819 Bacterial inhibition with an oligosaccharide compound
12/14/1999	US6001807 Administering therapetically effective amount of an antagonist for cortiocotropin releasing factor
12/14/1999	US6001653 Human type 2 RNase H
12/14/1999	US6001651 Antisense modulation of LFA-3
12/14/1999	US6001644 Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999	US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999	US6001578 Developing potential drugs for treating obesity, metabolic syndrome or non-insulin dependent diabetes mellitus; contacting cells expressing fat protein with modulating drug, culturing cells, detecting gene expression indicators
12/14/1999	US6001555 Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
12/14/1999	US6001395 Polymeric lamellar substrate particles for drug delivery
12/14/1999	US6001392 Antitussive drugs delivered by ion exchange resins
12/14/1999	US6001390 Formulations for transdermal delivery of pergolide
12/14/1999	US6001389 Compositions containing biologically active silicon
12/14/1999	US6001386 For treatment of uveitis eye disease
12/14/1999	US6001384 Administering composition for topical or parenteral use for controlling myiasis in cattle and sheep, with an effective larvicidal amount of fipronil
12/14/1999	US6001378 For treatment of the skin, the scalp or the hair, for fighting against the effects of ageing, for improving healing and tissue regeneration, for fighting against hair loss, improving hair re-growth or treating alopecia
12/14/1999	US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis
12/14/1999	US6001358 Useful for treatment of autoimmune diseases
12/14/1999	US6001347 Organic acid compound of given structure having an aromatic amide group, a methoxy group in the ortho position on the aromatic ring, and a lipophilic chain terminated with a carboxylic acid is useful as a nontoxic carrier
12/14/1999	US6001345 Application of cyanoacrylate/anti-microbial compositions to the peri-wound or peri-mucosal area
12/14/1999	US6001340 Topical compositions and methods for treating Pseudofolliculitis barbae and ingrown hair
12/14/1999	US6001336 Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
12/14/1999	CA2186485C An improved method of synthesis for 6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione and its dimaleate salt
12/14/1999	CA2175581C Desquamation compositions containing salicylic acid and zwitterionic compounds
12/14/1999	CA2172607C Phorbine derivatives and their use in the diagnosis and therapy of cancer
12/14/1999	CA2155910C Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
12/14/1999	CA2155024C Genetic modification of neural stem cells
12/14/1999	CA2138873C Composition against acne insuring the simultaneous treatment of the superficial and deep layers of the skin, and its use
12/14/1999	CA2136007C Novel compound with platelet aggregation inhibitor activity
12/14/1999	CA2135487C Heteroaromatic quinuclidinenes, their use and preparation
12/14/1999	CA2100258C Acridine derivatives
12/14/1999	CA2074503C Pharmaceutical formulation containing penciclovir
12/14/1999	CA2017767C Anticancer antibiotic mi43-37f11 substance, the production and uses thereof
12/14/1999	CA2014971C Inhibitive agent against activity of alpha-amylase
12/14/1999	CA2014555C Preventive and curative medicament against infection with influeza virus
12/14/1999	CA2010636C Substituted pyrroles
12/14/1999	CA1340850C Nisin compositions for use as enhanced, broad range bactericides
12/12/1999	CA2274733A1 New derivatives of 5,10-dihydrodipyrido[2,3-b:2,3-e]pyrazine and of 5,10- dihydrodipyrido[2,3-b:3,2-e]pyrazine, their preparation process and pharmaceutical compositions made thereof

1 ... 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 6415 6416 ... 7860